Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
LUNG Transcript
Pulmonx Corporation (LUNG) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Neutral5-12
Pulmonx Corporation (LUNG) Q1 2026 Earnings Call Transcript
Unknown4-30
The earnings call presents a mixed outlook. Financial performance shows improvement in net loss and operating expenses, yet cash reserves declined. The Q&A indicates confidence in future growth and sales strategies, but management's vague responses on certain metrics raise concerns. The guidance suggests positive future growth, but current financial metrics and lack of clear guidance on some fronts balance out the optimism, leading to a neutral sentiment.
Pulmonx Corporation (LUNG) Q4 2025 Earnings Call Transcript
Unknown3-4
The earnings call presents mixed signals. Financial performance shows improvements in net loss and EBITDA, but cash reserves are declining. The sales force restructuring is positive, yet growth is not expected until late 2026. Cost management is effective, but management's lack of clarity on key metrics raises concerns. Market conditions are favorable, but significant growth drivers like Japan and China are limited. Overall, the outlook is balanced, resulting in a neutral sentiment.
Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript
Unknown11-12
The earnings call reveals mixed financial results with modest revenue growth and increased expenses, particularly in R&D. The guidance revision downward and management's inability to provide clear answers during the Q&A suggest challenges in execution and strategic direction. While international growth and gross margin improvements are positives, the lack of clarity on U.S. growth and strategic pathways, along with cash burn, contribute to a negative sentiment. The market is likely to react negatively to these uncertainties, resulting in a potential stock price decline of -2% to -8%.
LUNG Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
